Home [sandbox] K4D COVID-19 Resource Hub

[sandbox] K4D COVID-19 Resource Hub

Protocol rss RSS 0 Protocol atom ATOM 0 Protocol json JSON 0
Sort by: Date tagged Date published
73 - 96 of 1176

A Tale Of Two Crises And The Solutions That Bind Them: Wild Polio And COVID-19

https://api.zotero.org/groups/2494380/items/Y6J22945?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

A step backwards in the fight against global vaccine inequities

https://api.zotero.org/groups/2494380/items/Y3CFHSKA?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

From governance to community surveillance: Assam’s 360 degree COVID-19 response

https://api.zotero.org/groups/2494380/items/UTAMZUH6?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Oxford–AstraZeneca COVID-19 vaccine efficacy

https://api.zotero.org/groups/2494380/items/VTT9GWXI?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

COVID-19 and Violence against Women and Children: A Third Research Round Up for the 16 Days of Activism

https://api.zotero.org/groups/2494380/items/HSVR36KP?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

The COVID-19 Vaccine: Do We Know Enough to End the Pandemic?

https://api.zotero.org/groups/2494380/items/NU4AYNBS?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Support for Rehabilitation: Self-Management after COVID-19 Related Illness

https://api.zotero.org/groups/2494380/items/5Z529FCZ?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 12/31/2020

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

https://api.zotero.org/groups/2494380/items/TLAQPAWG?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

Rapid Review: Vaccine Hesitancy and Building Confidence in COVID-19 Vaccination

https://api.zotero.org/groups/2494380/items/H5JER4U5?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

RCCE Strategies to Overcome COVID-19 Fatigue in the Eastern Mediterranean, Middle East and North Africa

https://api.zotero.org/groups/2494380/items/LV369XM2?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

Oxford University breakthrough on global COVID-19 vaccine | University of Oxford

https://api.zotero.org/groups/2494380/items/45RNBACE?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

Launching an Interactive Webtool to Analyse the COVID-19 Vaccine Portfolio

https://api.zotero.org/groups/2494380/items/SZLUJI5L?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

COVID-19 Vaccine Predictor

https://api.zotero.org/groups/2494380/items/MGSQQE4X?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

https://api.zotero.org/groups/2494380/items/S7RCXIC6?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

Policy makers must act on incomplete evidence in responding to COVID‐19

https://api.zotero.org/groups/2494380/items/UY35LG8Y?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine

https://api.zotero.org/groups/2494380/items/CWV4RUYR?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine | Pfizer

https://api.zotero.org/groups/2494380/items/ZJNNW7R9?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

WHO Guideline Development Group advises against use of remdesivir for covid-19 | BMJ

https://api.zotero.org/groups/2494380/items/YRLCXVPQ?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

Lessons from around the world on fighting COVID’s second wave

https://api.zotero.org/groups/2494380/items/YF9V2QMX?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

Strengthening pandemic preparedness and response begins with answering the question: where are the women?

https://api.zotero.org/groups/2494380/items/W44BZ4A2?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

On the recommendation of the data safety and monitoring board, @REMAP_CAP is declaring efficacy of #tocilizumab with an OR of 1.87 for benefit on a combination of survival and length of time patients received organ support in ICU, compared with standard care [...]

https://api.zotero.org/groups/2494380/items/3347JHRP?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

Age and frailty in COVID-19 vaccine development

https://api.zotero.org/groups/2494380/items/83EV5AU6?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

Ensuring access to essential sexual and reproductive health products during COVID-19: Challenges and future directions

https://api.zotero.org/groups/2494380/items/WYJS5KDL?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

The syndemic of COVID-19 and gender-based violence in humanitarian settings: leveraging lessons from Ebola in the Democratic Republic of Congo

https://api.zotero.org/groups/2494380/items/3R85WPP5?format=atom

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 11/27/2020

73 - 96 of 1176